ENGLISHHOMECONTACT USSITEMAP

제품정보
Kyongshin PRODUCT

Zymo Research

Bertin

Saphymo (Bertin)

Berthold

Serumwerk

Biocomp

Capitalbio

Arrayjet

PolyAn

Hudson Robotics

ABER instrument

Arthus Biosystems

BioChain

Povair

BIOREAGENT(Bertin)

BIOREAGENT(Bertin)
▪ HOME>제품정보>BIOREAGENT(Bertin)
DHN-MA Lipid Peroxidation ELISA kit
Lipid peroxidation is a well-established mechanism of cellular injury in both plants and animals and is used as an indicator of oxidative stress in cells and tissues.
서한형 대리
(010-8832-6303)

제품소개

Territorial Availability: Available worldwide directly through Bertin Bioreagent or your local distributor
Technical Warning: Check the Additional Items Required section of this kit booklet to verify if UltraPure Water (Milli-Q or equivalent) is needed for this assay
Product Overview: 
Lipid peroxidation is a well-established mechanism of cellular injury in both plants and animals and is used as an indicator of oxidative stress in cells and tissues.
Measurement of 4-hydroxy-2-nonenal (HNE), an aldehyde formed during the lipid peroxidation process, is one of several accepted biomarkers for lipid peroxidation. 1,4-Dihydroxynonane mercapturic acid (DHN-MA) is the major urinary metabolite of HNE present at physiological levels in rat and human urine. It can be measured without extraction and offers an alternative lipid peroxidation biomarker aside from 8-isoprostane or TBARS. This DHN-MA EIA Kit is a competitive assay that can be used for quantification of DHN-MA in urine samples. The EIA typically displays an IC50 (50% B/B0) of approximately 75 pg/ml and a detection limit (80% B/B0) of approximately 10 pg/ml.

Size: 96 wells
Shipping: dry ice
Stability: Store at -20degrees; shelf life 1 year maximum after production
Application Media: urine (other upon request)|No extraction required
Tracer: AcetylCholinesterase AChE
Detection Limit: 10 pg/mL
Standard Curve Range: 7,8-1000 pg/mL
Custom Code: 3822000000
UNSPSC code: 41116104

PRODUCT EXPLANATION: ACETYLCHOLINESTERASE MARKER IN ENZYME-IMMUNOASSAYS

Grassi J., Pradelles P. Compounds labelled by the acetylcholinesterase of Electrophorus Electricus. Its preparation process and its use as a tracer or marquer in enzymo-immunological determinations. United States patent, N° 1,047,330. September 10, 1991

Grassi J., Pradelles P. The use of Acetylcholinesterase as a Universal marker in Enzyme-Immunoassays. Proceedings of the Third International Meeting on Cholinesterases, American Chemical Society (1991)

Pradelles P., Grassi J., Maclouf J. Enzyme Immunoassays of Eicosanoids Using Acetylcholinesterase. Methods in Enzymology (1990), vol. 187, 24-34

PRODUCT EXPLANATION: DHN-MA

Spickett CM. The lipid peroxidation product 4-hydroxy-2-nonenal: Advances in chemistry and analysis. Redox Biol. 2013 Jan 21;1(1):145-152. eCollection 2013

Pierre F, Peiro G, Taché S, Cross AJ, Bingham SA, Gasc N, Gottardi G, Corpet DE, Guéraud F. New marker of colon cancer risk associated with heme intake: 1,4-dihydroxynonane mercapturic acid. Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2274-9

Peiro G, Alary J, Cravedi JP, Rathahao E, Steghens JP, Guéraud F. Dihydroxynonane mercapturic acid, a urinary metabolite of 4-hydroxynonenal, as a biomarker of lipid peroxidation. Biofactors. 2005;24(1-4):89-96

Zarkovic N. 4-hydroxynonenal as a bioactive marker of pathophysiological processes. Mol Aspects Med. 2003 Aug-Oct;24(4-5):281-91. Review

Uchida K, Szweda LI, Chae HZ, Stadtman ER. Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8742-6

Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 1991;11(1):81-128. Review

PRODUCT EXPLANATION: DHN-MA KIT DEVELOPMENT

Guéraud F, Peiro G, Bernard H, Alary J, Créminon C, Debrauwer L, Rathahao E, Drumare MF, Canlet C, Wal JM, Bories G. Enzyme immunoassay for a urinary metabolite of 4-hydroxynonenal as a marker of lipid peroxidation. Free Radic Biol Med. 2006 Jan 1;40(1):54-62. Epub 2005 Sep

Valentin MA, Ma S, Zhao A, Legay F, Avrameas A. Validation of immunoassay for protein biomarkers: Bioanalytical study plan implementation to support pre-clinical and clinical studies. J Pharm Biomed Anal. (2011) 55(5) : 869-877

European Medicines Agency. Guideline on bioanalytical method validation, 21 July 2011

주문정보

CAT.No 품명 규격 비고
A05033 DHN-MA Lipid Peroxidation ELISA kit 96 wells AChE kits